HAIs are estimated to cost €7billion in Europe each year3
In an ideal world, your institution would have zero heathcare-associated infection and zero outbreak.
Beyond high medical burden and cost, HAIs impact the hospital's image and reputation and lead to increased litigation costs.
The challenges to preventing and managing HAIs lie in the implementation of clinical practice–based measures (evidence-based practice interventions) and the use of technologic approaches (evidence-based technologic innovation interventions (devices and technology)4.
Diagnostic Systems is a global leader of products and instruments used for diagnosing infectious diseases. Our products are used in the clinical market to screen for microbial presence, grow and identify organisms, and test for antibiotic susceptibility.
Blood Collection
Improving sample quality by standardising processes and practices resulting in reduced sample collection errors, reduced retesting, greater diagnostic accuracy and faster and more consistent results.
References